The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2025 | Y-LUNG: investigating the rise of lung cancer in younger patients
Giannis Mountzios, MD, Henry Dunant Hospital, Athens, Greece, gives an overview of the Y-LUNG initiative, which aims to elucidate the mechanisms of carcinogenesis in young patients with lung cancer, particularly those under 45 years old, who often have never smoked and are not exposed to known environmental carcinogens. The initiative will investigate environmental, genetic, and occupational factors contributing to this trend. This interview took place at the European Lung Cancer Congress (ELCC) 2025 in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
